Over the last 7 days, the Clinical Research and Equipment industry has risen 1.1%, driven by gains in Divi's Laboratories and Syngene International of 0.8% and 2.7%, respectively. This takes the industry's 12 month performance to a gain of 21%. Looking forward, earnings are forecast to grow by 23% annually.
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 15 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 29.5x | 77.5x | 8.6x |
Wed, 13 Mar 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 30x | 73.2x | 8.1x |
Fri, 09 Feb 2024 | ₹1.4t | ₹166.6b | ₹19.0b | 33.2x | 74.5x | 8.5x |
Sun, 07 Jan 2024 | ₹1.5t | ₹155.9b | ₹18.1b | 23.8x | 80.8x | 9.4x |
Tue, 05 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.4x | 77.3x | 9x |
Thu, 02 Nov 2023 | ₹1.2t | ₹156.0b | ₹19.8b | 23.5x | 63.1x | 8x |
Sat, 30 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.4x | 71.8x | 9.1x |
Mon, 28 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 27.6x | 69.2x | 8.8x |
Wed, 26 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 30.1x | 60.2x | 8.9x |
Fri, 23 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28.8x | 57.2x | 8.4x |
Sun, 21 May 2023 | ₹1.2t | ₹160.8b | ₹22.9b | 32.9x | 51.6x | 7.3x |
Tue, 18 Apr 2023 | ₹1.2t | ₹159.5b | ₹28.4b | 33.4x | 40.9x | 7.3x |
Thu, 16 Mar 2023 | ₹1.0t | ₹159.5b | ₹28.4b | 30.7x | 36.9x | 6.6x |
Sat, 11 Feb 2023 | ₹1.1t | ₹158.9b | ₹28.3b | 34.2x | 37.2x | 6.6x |
Mon, 09 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30.5x | 35.8x | 7.5x |
Wed, 07 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 34x | 35.3x | 7.4x |
Fri, 04 Nov 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 37.5x | 37.3x | 8.2x |
Sun, 02 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.2x | 36.2x | 8x |
Tue, 30 Aug 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 37x | 35.8x | 7.9x |
Thu, 28 Jul 2022 | ₹1.3t | ₹159.0b | ₹34.4b | 34x | 38.4x | 8.3x |
Sat, 25 Jun 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 33x | 37.6x | 8.1x |
Mon, 23 May 2022 | ₹1.4t | ₹149.9b | ₹30.3b | 34.9x | 47.9x | 9.7x |
Wed, 20 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 37.3x | 51.7x | 10.2x |
Fri, 18 Mar 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 35.5x | 52.3x | 10.4x |
Sun, 13 Feb 2022 | ₹1.5t | ₹139.8b | ₹25.1b | 37.6x | 59.1x | 10.6x |
Tue, 11 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 35.9x | 63.1x | 11.3x |
Thu, 09 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 31.6x | 64.1x | 11.4x |
Sat, 06 Nov 2021 | ₹1.7t | ₹132.3b | ₹22.7b | 23.8x | 74.2x | 12.7x |
Mon, 04 Oct 2021 | ₹1.6t | ₹131.1b | ₹22.9b | 22.7x | 70x | 12.3x |
Wed, 01 Sep 2021 | ₹1.7t | ₹131.4b | ₹22.9b | 25.2x | 74.4x | 13x |
Thu, 08 Jul 2021 | ₹1.5t | ₹127.1b | ₹22.6b | 36.9x | 65.2x | 11.6x |
63.4x
How does Indian Clinical Research and Equipment compare with similar industries?
IN Market | -0.034% | |
Healthcare | -1.04% | |
Life Sciences | 1.11% | |
Clinical Research and Equipment | 1.11% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
INNOVACAP Innova Captab | ₹485.75 | 3.9% +₹1.1b | n/a | PE33.5x | |
TARSONS Tarsons Products | ₹453.00 | 3.4% +₹790.0m | -17.4% | PE44.1x | |
511509 Vivo Bio Tech | ₹45.44 | 4.0% +₹26.2m | 85.9% | PE17.6x | |
538837 Jeevan Scientific Technology | ₹51.83 | 2.3% +₹18.4m | 2.1% | PS2.2x | |
539267 Samsrita Labs | ₹15.61 | 0.4% +₹888.5k | -21.6% | PS1065.3x |